New anticoagulant may prevent recurrent ischemic stroke
The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with […]
Learn more →Half Mag / Half Zine
The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with […]
Learn more →Asundexian 50 mg administered to post-myocardial infarction patients inhibits factor XIa by more than 90% with no significant increase in […]
Learn more →An estimated 5 to 10% of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in […]
Learn more →Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and […]
Learn more →Clinical data and cardiac magnetic resonance (CMR) imaging did not improve risk prediction for sudden cardiac death (SCD) after myocardial […]
Learn more →The fight against a devastating lung condition in newborn babies could be helped by the discovery that it is caused […]
Learn more →A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and […]
Learn more →